Hot News

Advanced Biomedical Technology awarded Taiwan Government Grant (FY2019-2020)

Advanced Biomedical Technology Inc. has received two grants from the Ministry of Science and Technology (MOST) this year.   2019 Biomedical Leap Projects for Cross-industry Integration and 2019 R&D and innovation-based Industry-academia Collaboration Projects are most important and prospective government science project in Taiwan for all company which based in Science Park.

From these two projects, ABT Inc. is going to collaborate with plastic & reconstructive surgery department to define and discover the potential treatment strategy and benefits for microtia patients by using ABTs medical 3D printing total solution.

ABTs novel AM system aims at providing a next-generation total solution for medical 3D printing application. said Dr. Bruce Chen, CEO of ABT.   Additive manufacturing is becoming an ideal way to help surgeons get curve fitting and complex structure implant. It could save time to process the traditional implant before the surgery, especially for the implant will affect the appearance shape of patients. The government grant could help us collaborate with doctors and find out the best way to link customization service with the hospital.

Advanced Biomedical Technology Inc. (ABT Inc.) is a start-up located in Hsinchu Science Park who specialized in developing medical-grade material and service for medical 3D printing applications. Focus on providing realizable different medical grade 3D printing material and one-stop shop medical implant printing service to clients.

Advanced Biomedical Technology Inc., the first company in Taiwan, receives the FDA-announced Device Master File registering for biodegradable 3D-printing materials.

Advanced Biomedical Technology Inc., the first company in Taiwan, receives the FDA-announced Device Master File registering for biodegradable 3D-printing materials.

Advanced Biomedical Technology Inc. receives Device Master File (MAF) acknowledgment letter from FDA of the MeDFila® PCL-Ceramic 3D printing filament.

Advanced Biomedical Technology Inc. has successfully submitted a Device Master File to the Center for Devices and Radiological Health (CDRH) at the FDA for MeDFila®, their additive manufacturing (AM) PCL-Ceramic printing filament and received an Acknowledgment letter from the FDA confirming submission filing. For the medical device manufacturer, this MAF is now available for reference and review at the FDA.

“This MAF brings the MeDFila® another step closer to becoming the material of choice for medical 3D printing application and custom personal implant,” said Dr. Bruce Chen, CEO. “We will continue to deliver different composite material for medical 3D printing, which is a huge and growing market.”

Advanced Biomedical Technology Inc. shall provide MAF authorization letter on customer requests for their FDA’s review in the context of their product registration.

MeDFila® PCL series MAF status:

MAF Ready:

MeDFila® PCL-Ceramic (70%:30%) ; MAF Ready

Under FDA review process, MAF coming soon.

MeDFila® PCL ; MAF soon

MeDFila® PCL-Ceramic (50%:50%) ; MAF soon

MeDFila® PCL-Ceramic (60%:40%) ; MAF soon

For more information about MeDFila®

Please contact us for further information.

光宇生醫科技:公告本公司收到美國FDA通知,本公司可降解3D列印材料MeDFila®獲准原料主檔案之建立。

光宇生醫科技股份有限公司,宣布已收到美國食品藥物管理局 (Food and Drug Administration, FDA)通知,該公司聚己內酯陶瓷可降解3D列印材料MeDFila®獲准原料主檔案(Device Master File,MAF)之建立。此份MAF可提供未來使用MeDFila®材料製作醫療器材之客⼾,在產品申請美國上市許可時,作為其產品在FDA技術檔案審查時之⽤。

光宇生醫所生產之MeDFila®可降解3D列印材料獲准MAF之建立,亦代表使用者可使用安全可靠的生物可降解列印材料MeDFila®,以3D列印或稱積層製造(Additive Manufacturing, AM),進⾏生物醫療領域應⽤與產品開發。目前國際上核可用於生醫領域3D列印材料種類與供應商仍在少數,本公司為目前國內唯一取得相關材料MAF之供應商,並已接獲來自醫療器材製造商、藥廠、研究單位等國際客戶之需求與訂單,並開始進⾏供貨。

2019-04-01 上午10.29.21

根據相關市場資料指出,醫療應用約佔整體3D列印應用市場比例的15%左右,截至2018年為止,全球3D列印醫療/醫療保健市場的價值預估為11.4億美元,預計到2025年底將達到73.6億美元,2019年至2025年期間的複合年增長率為26.2%,顯⽰出3D列印醫療應用在未來的高度成長性。根據IndustryARCThe Wall Street Journal資料整理,3D列印應⽤在醫療領域主要可分為:1. 牙科植體 2. 植入物 3. 義肢 4. 助聽器 5. 手術導引 6. 醫療零件 7. 藥物篩選 8. 組織工程 9. 其他,這九大類主流應⽤。光宇生醫所發展的MeDFila®系列材料,可提供3D列印生醫應用領域裡,牙科、植入物、醫療零件、藥物篩選、組織工程等類別的應用市場。

積層製造醫療應用已經開始進入蓬勃發展的階段,預期本公司MeDFila®系列材料,將可從源頭供應給予相關客戶做應用,縮短客戶在產品開發與增加產品發展應用之可能性。

Medical 3D Printing Material — Polycaprolactone (PCL)

PCL has been approved by the FDA and offers a suitable material for 3D printing scaffolds due to high crystallinity and a low melting point. ….. The materials are already in use for a wide range of medical needs, including cranial repairs, screws to fix bone fractures, systems with sustained-release mechanisms, and already for use as a 3D printing matrix for hydroxyapatite scaffolds. PCL is also a bioabsorbable material that is deemed exceptionally safe…..

Due to high integration of new technology and biomaterials composite, There are more and more new preclinical animal study and human case study for distinct indication. For better bone integration with biodegradable polymer and ceramics mixture. Our MeDFila® PCL series offer alternative medical grade filament for such research topic and easier to bridge to product realization( or commercialization). Welcome all researcher from industrial and academic for further collaboration. For more information about PCL series filaments, please visit MeDFila®.

MeDFila® PCL series online store.

Article resource:

Sichuan University Researchers Examine Four Levels of 3D Printed PCL Scaffolds

MEDICAL-GRADE BIODEGRADABLE 3D PRINTING FILAMENT, PRINTING SYSTEM, AND CUSTOMIZED SERVICE @ Taiwan Healthcare+ EXPO 11.29-12.02 2018

Welcome to visit us @ 2018 Taiwan Healthcare+ EXPO  11/29-12/2

Booth: I1307

2018-11-26 上午10.27.36

A PORTAL to world-class medical teams and cutting-edge bio companies in Taiwan. 
Taiwan Healthcare+ provides anyone, anywhere in the world with convenient access to high-quality medical services and the burgeoning biotechnology industry in Taiwan, all certified and quality assured. This year, Advanced Biomedical Technology will show our medical grade 3D printing biodegradable filament – MeDFila® and future scenario of 3D printing service for medical application. Welcome to visit us and find out the potential of 3D printing at booth I1307. 

Expo_LOGO

 

Medical-grade biodegradable 3D printing filament, printing system, and customized service @ Formnext 2018!

螢幕快照 2018-10-31 上午10.58.10

Formnext is more than an exhibition and conference. It’s an entire platform for companies from the world of additive manufacturing. This year, Advanced Biomedical Technology will show our MeDFila® product portfolio for medical application. Welcome to visit us and find out the potential of biodegradable 3D printing filaments at booth B30E.

Are you planning to go to Formnext, but haven’t registered yet? Contact us to redeem a free of charge entry voucher.   螢幕快照 2018-10-31 下午2.10.33


螢幕快照 2018-10-31 上午11.32.40

MeDFila® is a brand of biodegradable 3D printing filaments with various composition of materials.

螢幕快照 2018-10-31 下午2.17.35


螢幕快照 2018-10-31 上午11.30.52

Total Solution for you! We provide materials, printing system, and customized printing service for your innovative medical devices project. Take a look at our products and services.

螢幕快照 2018-10-31 下午2.20.19

See you @ formnext! Check our medical-grade biodegradable 3D printing filaments—MeDFila

螢幕快照 2018-10-30 下午2.42.48
Where will you be during Nov. 13-16? ABT team will be in Frankfurt, Germany at the formnext international exhibition. Visit us at our booth B30E! Welcome to see our medical-grade biodegradable 3D printing filaments MeDFilaTM and discuss your medical devices project with us. Get more information about formnext.
please visit: formnext 

Workshop | Application of biodegradable medical-grade filaments

Our CEO Bruce Chen was invited to give a talk about the application of biodegradable 3DP material for orthopedic implant at Shanghai Ninth People’s Hospital, Shanghai JiaoTong University Schools of Medicine in China.

Shanghai Ninth People’s Hospital is a leading hospital which provides 3D printing medical service to patients. In the meeting, Bruce shared his professional experience and accomplishments in biomaterial and demonstrate the potential application of medical-grade 3D printing filament “MeDFila” for the orthopedic implant. To know more about MeDFila, please visit: MeDFila

合影留念

Material getting involv more in 3D printing

The world leading chemical company head into AM field with a strategic partner. It’s shown the great and bright future with AM integration with raw materials supplier. And we both find the image processing and materials property are synergized for better application. See the news”Optimizing materials and software for 3D printing

As a medical-grade 3D printing material provider, we believe this kind of cooperation will become more and more important, especially in medical application territory.

To see medical-grade material MeDFila.

banner-01 (1)

Using 3D Printing for Tissue Engineering Research?

Additive manufacturing (AM) has become popular and significant potential as a fabrication method in creating different type of scaffold for tissue engineering.  A researcher could easy to create a proper structure for a specific purpose by 3D printing. However, to choose a right material with good quality is very important for a successful research. MeDFila is a high-quality biodegradable 3D printing filament as an ideal material to make your scaffold for your tissues engineering research.

>To know more about MeDFila.

>To follow us on Linkedin.

 

Using 3D Printing for Orthopedic Research?

Additive Manufacture (AM) process had become popular in medical fields. Especially in the orthopedic field. Our filaments are design for those who are looking for medical-grade 3D printing filament to apply their idea in medical application. To know more about MeDFila please visit MeDFila.

New office for Advanced Biomedical Technology Inc, in Hsinchu Science Park

Advanced Biomedical Technology Inc, (ABT) announced that its office in Hsinchu Biomedical Park, which was first opened in 2016, has now relocated to a larger facility in the Hsinchu Science Park.

圖片 1 (2)
The new headquarters office of Advanced Biomedical Technology in Hsinchu, Taiwan

Bruce Chen, CEO of ABT said “As a medical grade biodegradable material and biomedical additive manufacturing (AM) solution provider, we keep ahead and show our long-term commitment to provide high-quality biodegradable materials for additive manufacturing in the medical field. This facility combines our R&D and most advanced production plant, could provide our customers not only a single product but also a one-stop shop medical device development and manufacturing service with our own AM solution in the future.”

He continues, “In the past year, we made a great leap. Now we keep moving on to the next step to provide high-quality medical grade filaments to our customers and to discover more AM application in the medical field with our partner and customers.”

Contact details for the new office:

Advanced Biomedical Technology, Inc.
3F., No.22, Zhanye 2nd Rd., East Dist.,

Hsinchu City 300, Taiwan

Tel:   +886 3 6686948
Fax:   +886 3 6686894
E-mail: info@advbiomedtech.com

About Advanced Biomedical Technology, Inc.

Advanced biomedical technology (ABT) is a start-up who focusing on developing biodegradable material for 3D printing and 3D printing medical implant. ABT provides high-quality medical-grade biodegradable filaments for additive manufacturing application. In addition, ABT provides design, development and manufacturing service of medical implants to our customer.

Discover the potential of biodegradable 3D printing filament with us @ formnext 2018 13~16 November in Germany.

Are you ready to go to formnext show at Frankfurt, Germany? Don’t forget to visit us at start-up area booth 3.1. Bring your business card and exchange a free secret gift at our booth.

Planning to go to Formnext, but haven’t registered yet? Contact us to redeem a free of charge entry voucher. ==>Link

螢幕快照 2018-11-05 下午3.38.10